(Reuters) - Britain's Indivior fell by more than 20 percent on Friday after the U.S Food and Drug Administration (FDA) approved the first generic... ...http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/OdCZj0r_IZM/indivior-shares-dive-after-dr-reddys-gets-fda-approval-for-generic-idINKBN1JB16D
Posted by Equitymaster After opening the day flat share markets in India are trading on a dull note and are presently trading below the dotted... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/sAhTvOPfRWc/tm.asp
Posted by Equitymaster Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.4% while the Hang... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/YNzb-CkBtic/tm.asp
Posted by Equitymaster Indian share markets ended lower after the US Federal Reserve raised interest rates and took a more hawkish tone in... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/FAK7gvb_eHk/tm.asp
The company has launched the product as it has received an approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a... ...https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-antibiotic-inhalation-solution-in-us/articleshow/64574026.cms
An additional reason precisely why...